UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000019674 |
|---|---|
| Receipt number | R000022733 |
| Scientific Title | An Open Label Phase II Biomarker Study of Nivolumab the anti-PD-1 antibody in Japanese Subjects with pretreated non-small cell lung cancer. |
| Date of disclosure of the study information | 2015/11/20 |
| Last modified on | 2021/05/11 09:34:06 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/11/06 23:19:26 | ||
| 2 | Update | 2015/12/25 23:58:41 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2017/04/02 20:07:12 | Recruitment status Last follow-up date |
|
| 4 | Update | 2019/05/09 09:21:21 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Zip code Last name of contact person Last name of contact person Organization Zip code Name of primary person or sponsor Institute Organization Organization Organization Address Address Tel |
|
| 5 | Update | 2021/05/11 09:32:08 | Publication of results Number of participants that the trial has enrolled Results Delayed Results Delay Reason Results Delay Reason |
|
| 6 | Update | 2021/05/11 09:34:06 | Date of IRB |
